These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 10797439

  • 1. Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma.
    Tachibana I, Smith JS, Sato K, Hosek SM, Kimmel DW, Jenkins RB.
    Am J Med Genet; 2000 May 15; 92(2):136-41. PubMed ID: 10797439
    [Abstract] [Full Text] [Related]

  • 2. Lack of germ-line mutations of CDK4, p16(INK4A), and p15(INK4B) in families with glioma.
    Gao L, Liu L, van Meyel D, Cairncross G, Forsyth P, Kimmel D, Jenkins RB, Lassam NJ, Hogg D.
    Clin Cancer Res; 1997 Jun 15; 3(6):977-81. PubMed ID: 9815774
    [Abstract] [Full Text] [Related]

  • 3. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
    Watanabe T, Katayama Y, Yoshino A, Komine C, Yokoyama T.
    Clin Cancer Res; 2003 Oct 15; 9(13):4884-90. PubMed ID: 14581362
    [Abstract] [Full Text] [Related]

  • 4. Quantitative real-time PCR does not show selective targeting of p14(ARF) but concomitant inactivation of both p16(INK4A) and p14(ARF) in 105 human primary gliomas.
    Labuhn M, Jones G, Speel EJ, Maier D, Zweifel C, Gratzl O, Van Meir EG, Hegi ME, Merlo A.
    Oncogene; 2001 Mar 01; 20(9):1103-9. PubMed ID: 11314047
    [Abstract] [Full Text] [Related]

  • 5. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A, Busse C, Weinans L, Benicke M, Katalinic A, Geissler F, Hauss J, Wittekind C.
    Oncogene; 2001 Oct 25; 20(48):7104-9. PubMed ID: 11704835
    [Abstract] [Full Text] [Related]

  • 6. Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas.
    Cheng Y, Pang JC, Ng HK, Ding M, Zhang SF, Zheng J, Liu DG, Poon WS.
    Histopathology; 2000 Nov 25; 37(5):437-44. PubMed ID: 11119125
    [Abstract] [Full Text] [Related]

  • 7. Survey of familial glioma and role of germline p16INK4A/p14ARF and p53 mutation.
    Robertson LB, Armstrong GN, Olver BD, Lloyd AL, Shete S, Lau C, Claus EB, Barnholtz-Sloan J, Lai R, Il'yasova D, Schildkraut J, Bernstein JL, Olson SH, Jenkins RB, Yang P, Rynearson AL, Wrensch M, McCoy L, Wienkce JK, McCarthy B, Davis F, Vick NA, Johansen C, Bødtcher H, Sadetzki S, Bruchim RB, Yechezkel GH, Andersson U, Melin BS, Bondy ML, Houlston RS.
    Fam Cancer; 2010 Sep 25; 9(3):413-21. PubMed ID: 20455025
    [Abstract] [Full Text] [Related]

  • 8. Germline mutations of p53 but not p16/CDKN2 or PTEN/MMAC1 tumor suppressor genes predispose to gliomas. The ANOCEF Group. Association des NeuroOncologues d'Expression Française.
    Zhou XP, Sanson M, Hoang-Xuan K, Robin E, Taillandier L, He J, Mokhtari K, Cornu P, Delattre JY, Thomas G, Hamelin R.
    Ann Neurol; 1999 Dec 25; 46(6):913-6. PubMed ID: 10589545
    [Abstract] [Full Text] [Related]

  • 9. Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes.
    Soufir N, Bressac-de Paillerets B, Desjardins L, Lévy C, Bombled J, Gorin I, Schlienger P, Stoppa-Lyonnet D.
    Br J Cancer; 2000 Feb 25; 82(4):818-22. PubMed ID: 10732752
    [Abstract] [Full Text] [Related]

  • 10. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation.
    Smeds J, Berggren P, Ma X, Xu Z, Hemminki K, Kumar R.
    Carcinogenesis; 2002 Apr 25; 23(4):645-55. PubMed ID: 11960918
    [Abstract] [Full Text] [Related]

  • 11. Contribution of germline mutations in BRCA2, P16(INK4A), P14(ARF) and P15 to uveal melanoma.
    Hearle N, Damato BE, Humphreys J, Wixey J, Green H, Stone J, Easton DF, Houlston RS.
    Invest Ophthalmol Vis Sci; 2003 Feb 25; 44(2):458-62. PubMed ID: 12556369
    [Abstract] [Full Text] [Related]

  • 12. INK4a/ARF locus alterations in human non-Hodgkin's lymphomas mainly occur in tumors with wild-type p53 gene.
    Pinyol M, Hernández L, Martínez A, Cobo F, Hernández S, Beà S, López-Guillermo A, Nayach I, Palacín A, Nadal A, Fernández PL, Montserrat E, Cardesa A, Campo E.
    Am J Pathol; 2000 Jun 25; 156(6):1987-96. PubMed ID: 10854221
    [Abstract] [Full Text] [Related]

  • 13. Association between INK4a-ARF and p53 mutations in skin carcinomas of xeroderma pigmentosum patients.
    Soufir N, Daya-Grosjean L, de La Salmonière P, Moles JP, Dubertret L, Sarasin A, Basset-Seguin N.
    J Natl Cancer Inst; 2000 Nov 15; 92(22):1841-7. PubMed ID: 11078762
    [Abstract] [Full Text] [Related]

  • 14. p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma.
    Fulci G, Labuhn M, Maier D, Lachat Y, Hausmann O, Hegi ME, Janzer RC, Merlo A, Van Meir EG.
    Oncogene; 2000 Aug 03; 19(33):3816-22. PubMed ID: 10949938
    [Abstract] [Full Text] [Related]

  • 15. Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines.
    Ishii N, Maier D, Merlo A, Tada M, Sawamura Y, Diserens AC, Van Meir EG.
    Brain Pathol; 1999 Jul 03; 9(3):469-79. PubMed ID: 10416987
    [Abstract] [Full Text] [Related]

  • 16. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas.
    Calogero A, Arcella A, De Gregorio G, Porcellini A, Mercola D, Liu C, Lombari V, Zani M, Giannini G, Gagliardi FM, Caruso R, Gulino A, Frati L, Ragona G.
    Clin Cancer Res; 2001 Sep 03; 7(9):2788-96. PubMed ID: 11555594
    [Abstract] [Full Text] [Related]

  • 17. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.
    Caca K, Feisthammel J, Klee K, Tannapfel A, Witzigmann H, Wittekind C, Mössner J, Berr F.
    Int J Cancer; 2002 Feb 01; 97(4):481-8. PubMed ID: 11802210
    [Abstract] [Full Text] [Related]

  • 18. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
    Boström J, Meyer-Puttlitz B, Wolter M, Blaschke B, Weber RG, Lichter P, Ichimura K, Collins VP, Reifenberger G.
    Am J Pathol; 2001 Aug 01; 159(2):661-9. PubMed ID: 11485924
    [Abstract] [Full Text] [Related]

  • 19. Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland.
    Weber A, Langhanki L, Schütz A, Wittekind C, Bootz F, Tannapfel A.
    J Pathol; 2002 Nov 01; 198(3):326-34. PubMed ID: 12375265
    [Abstract] [Full Text] [Related]

  • 20. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
    Weber A, Bellmann U, Bootz F, Wittekind C, Tannapfel A.
    Virchows Arch; 2002 Aug 01; 441(2):133-42. PubMed ID: 12189502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.